About Us
Medical Blog

  • J&J Acquires Abiomed for $16.6 Billion

    By Brandon Smith on November 15, 2022 | Leave a response
    Johnson & Johnson ("J&J") announced on November 1, 2022, that it will acquire Abiomed for an upfront payment of $380.00 per share in cash, which equates to about $16.6 billion.  The acquisition is expected to be completed in the first quarter of 2023.  According to reports, after the acquisition, Abiomed "will operate as a standalone business within J&J within Johnson & Johnson M ...

  • Report: Medical Device Market Expected to Grow Over Next Seven Years

    By Raina Patel on November 3, 2022 | Leave a response
    An article from October 2022 states that the global medical device market is projected to jump by seven billion dollars in 2022 and leap to $223 billion over the next seven years, to reach a valuation of around $719 billion by 2029. A report by consulting firm Fortune Business Insights anticipates a 5.5% compound annual growth rate (CAGR) over this period. The report identifies several factors ...

  • FDA Grants Breakthrough Device Designation for EndoStim’s GERD Treatment

    By Christian Boettcher on October 27, 2022 | Leave a response
    EndoStim announced on October 25th that the FDA granted a breakthrough device designation for the company’s implantable neurostimulation treatment for drug refractory gastroesophageal reflux disease (GERD). EndoStim states that its EndoStim System is the first-in-class implantable neurostimulation treatment for GERD. While traditional surgery for the treatment of GERD requires wrapping the sto ...
Conferences